Anti LKM (Anti Liver Kidney Microsomal Abs) at Test Zone Diagnostic Center

Anti LKM (Anti Liver Kidney Microsomal Abs) at Test Zone Diagnostic Center

Autoimmune hepatitis (AIH) is a chronic, progressive inflammatory liver disease characterized by the presence of autoantibodies, hypergammaglobulinemia, and interface hepatitis on histological examination. Among the key serological markers used to classify and diagnose this condition is the Anti-Liver Kidney Microsomal (Anti-LKM) antibody, specifically Anti-LKM-1. At Test Zone Diagnostic Center in Lahore, Pakistan, we offer the highly precise Anti LKM (Anti Liver Kidney Microsomal Abs) test to assist clinicians in distinguishing between different types of autoimmune hepatitis and other chronic liver disorders. This laboratory investigation plays a pivotal role in identifying Autoimmune Hepatitis Type 2 (AIH-2), a relatively rare but aggressive form of liver disease that predominantly affects children and young adults.

The Anti-LKM antibody test works by detecting autoantibodies directed against the cytochrome P450 2D6 (CYP2D6) enzyme, a microsomal antigen highly expressed in both hepatocytes and the proximal renal tubules of the kidneys. By utilizing advanced immunological assays such as Enzyme-Linked Immunosorbent Assay (ELISA) or Indirect Immunofluorescence (IIF), Test Zone Diagnostic Center ensures the highest level of diagnostic sensitivity and specificity. Understanding the presence and titer of these antibodies is crucial for establishing an early diagnosis, initiating appropriate immunosuppressive therapy, and preventing the rapid progression of hepatic inflammation to irreversible cirrhosis or liver failure.

Clinical Procedure: What to Expect

Patient Preparation

• Inform your physician about all current medications, especially immunosuppressants, corticosteroids, or biological therapies, as these can affect antibody levels.
• No strict fasting is typically required for the Anti-LKM antibody test; however, your physician may advise a brief fasting period (8 to 12 hours) if other concurrent liver function tests (LFTs) or lipid profiles are scheduled.
• Ensure adequate hydration prior to the blood draw, as this makes venipuncture easier and more comfortable.
• Avoid strenuous physical exercise immediately before the test to prevent transient alterations in blood parameters.
• Bring your doctor’s prescription and any previous liver-related laboratory reports to Test Zone Diagnostic Center for clinical correlation.

During the Procedure

• Upon arrival at Test Zone Diagnostic Center, you will be guided to a comfortable blood collection station.
• A certified phlebotomist will verify your identity and explain the venipuncture procedure.
• The phlebotomist will inspect your arm to locate a suitable vein, typically in the antecubital fossa (the crook of the elbow).
• An antiseptic wipe (usually 70% isopropyl alcohol) will be used to thoroughly clean the skin surface over the selected vein to prevent contamination.
• A sterile tourniquet will be applied a few inches above the puncture site to increase venous pressure and make the vein more visible and accessible.
• A sterile, single-use needle attached to a vacuum collection tube (typically a serum separator tube or red-top tube) will be gently inserted into the vein.
• You may feel a brief, minor pinch or sting as the needle enters the skin.
• Once the required volume of blood is collected, the tourniquet is released, and the needle is carefully withdrawn.
• Pressure will be applied to the puncture site with a sterile cotton ball or gauze pad to promote hemostasis, followed by the application of an adhesive bandage.
• The entire sample collection process takes less than five minutes, and patients can immediately resume their daily activities.

When is a Anti LKM (Anti Liver Kidney Microsomal Abs) Performed?

Evaluation of Suspected Autoimmune Hepatitis Type 2 (AIH-2)

Autoimmune hepatitis is broadly categorized into Type 1 and Type 2 based on serological profiles. Type 2 AIH is characterized by the presence of Anti-LKM-1 antibodies and often presents in childhood or adolescence. Physicians request this test when a patient, particularly a young female, exhibits signs of acute or chronic liver dysfunction without an obvious viral, metabolic, or toxic cause. Early detection of AIH-2 is critical because it tends to have a more severe, fluctuating clinical course and a higher propensity to progress to cirrhosis compared to Type 1.

Investigation of Unexplained Elevated Liver Enzymes

When routine blood panels reveal persistently elevated levels of transaminases—specifically Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST)—without a clear etiology, the Anti-LKM test is indicated. Persistent transaminitis indicates ongoing hepatocellular injury. By evaluating the presence of liver-kidney microsomal antibodies, clinicians can rule out or confirm an autoimmune origin, allowing for targeted therapeutic interventions rather than empirical management.

Differential Diagnosis of Chronic Active Hepatitis

Chronic active hepatitis can stem from multiple etiologies, including viral infections (such as Hepatitis B, C, or D), non-alcoholic fatty liver disease (NAFLD), drug-induced liver injury (DILI), and Wilson’s disease. The Anti-LKM antibody test serves as a vital diagnostic tool in the differential workup. Distinguishing autoimmune hepatitis from viral or drug-induced hepatitis is essential because the treatment paradigms are vastly different; immunosuppressive therapy is the cornerstone of AIH management but could be detrimental in certain viral infections if not carefully managed.

Assessment of Pediatric Patients with Acute Liver Failure

Pediatric acute liver failure is a medical emergency that requires rapid diagnostic evaluation to identify treatable causes. Autoimmune hepatitis Type 2 can present precipitously as acute liver failure in children. The rapid turnaround of the Anti-LKM test at Test Zone Diagnostic Center assists pediatric gastroenterologists and hepatologists in quickly establishing a diagnosis of AIH-2, facilitating the immediate initiation of life-saving corticosteroid therapy or preparation for liver transplantation.

Monitoring Patients with Overlapping Autoimmune Disorders

Patients diagnosed with other autoimmune conditions, such as Type 1 diabetes, autoimmune thyroiditis, vitiligo, or celiac disease, have a higher genetic predisposition to developing autoimmune hepatitis. If these patients develop even mild liver enzyme abnormalities, clinicians frequently order the Anti-LKM antibody test. This proactive screening helps detect subclinical or early-stage autoimmune liver involvement before significant, irreversible parenchymal damage occurs.

What Does a Anti LKM (Anti Liver Kidney Microsomal Abs) Detect?

The Anti LKM (Anti Liver Kidney Microsomal Abs) test is capable of detecting several critical serological and clinical parameters, including:

• High titers of Anti-LKM-1 antibodies, strongly indicative of active Autoimmune Hepatitis Type 2 (AIH-2).
• Low or borderline titers of Anti-LKM-1 antibodies, requiring clinical correlation and potential serial testing.
• Negative Anti-LKM-1 antibody status, suggesting a lower probability of Autoimmune Hepatitis Type 2.
• Presence of Anti-LKM-2 antibodies, historically associated with drug-induced hepatitis (e.g., induced by ticrynafen).
• Presence of Anti-LKM-3 antibodies, which can be observed in a subset of patients with chronic Hepatitis D virus (HDV) infection.
• Concomitant elevation of Anti-Liver Cytosol Type 1 (Anti-LC1) antibodies, which frequently co-exist with Anti-LKM-1 in AIH-2.
• Absence of Antinuclear Antibodies (ANA), a classic finding in pure Autoimmune Hepatitis Type 2.
• Absence of Anti-Smooth Muscle Antibodies (ASMA), which helps differentiate AIH-2 from Autoimmune Hepatitis Type 1.
• Significant elevation of serum Immunoglobulin G (IgG) levels, reflecting systemic immune activation.
• Marked elevation of Alanine Aminotransferase (ALT), indicating active hepatocellular inflammation and necrosis.
• Marked elevation of Aspartate Aminotransferase (AST), correlating with the severity of liver cell injury.
• Elevated Total Bilirubin levels, indicating impaired hepatic excretion or severe parenchymal damage.
• Elevated Direct (Conjugated) Bilirubin, suggesting hepatocellular or cholestatic injury pathways.
• Normal or mildly elevated Alkaline Phosphatase (ALP) levels, helping rule out primary biliary cholangitis (PBC).
• Decreased Serum Albumin levels, indicating compromised synthetic function of the liver in chronic or advanced stages.
• Prolonged Prothrombin Time (PT) and elevated International Normalized Ratio (INR), reflecting impaired synthesis of coagulation factors.
• Seronegativity for Hepatitis B Surface Antigen (HBsAg), ruling out active HBV infection as the cause of liver injury.
• Seronegativity for Hepatitis C Virus (HCV) antibodies, ruling out chronic HCV-induced liver disease.
• Identification of autoimmune-mediated targeting of the cytochrome P450 2D6 (CYP2D6) antigen.
• Serological evidence supporting Autoimmune Polyglandular Syndrome Type 1 (APS-1) in patients with multi-organ autoimmunity.
• Fluctuations in antibody titers over time, which may correlate with disease activity or response to immunosuppressive therapy.
• Persistent antibody positivity despite biochemical remission, indicating a high risk of relapse upon treatment withdrawal.
• Cross-reactivity patterns in patients with chronic viral hepatitis, necessitating careful clinical and histological correlation.
• Serological markers consistent with pediatric-onset autoimmune liver disease.
• Absence of antimitochondrial antibodies (AMA), further distinguishing AIH-2 from primary biliary cholangitis.

Turnaround Time and Report Access at Test Zone Diagnostic Center

At Test Zone Diagnostic Center, we understand that timely diagnostic results are critical for clinical decision-making, particularly in acute or progressive liver conditions. The Anti LKM (Anti Liver Kidney Microsomal Abs) test is performed using state-of-the-art automated immunoassay platforms. Typically, the turnaround time for this specialized serological test is within 24 to 48 hours of sample collection. Once the analysis is complete, the report undergoes a rigorous multi-level verification process by our qualified clinical pathologists to ensure absolute accuracy. Patients and referring physicians receive an automated SMS notification as soon as the report is ready. Reports can be securely accessed and downloaded online via the Test Zone Diagnostic Center web portal or mobile application, providing maximum convenience and eliminating the need for a physical visit to collect paper reports.

Anti LKM (Anti Liver Kidney Microsomal Abs) Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Anti-LKM-1 Antibody Titer	Negative (No detectable antibodies)	Positive (Titer >= 1:20 in children or >= 1:40 in adults, indicating AIH-2)
Alanine Aminotransferase (ALT)	7 to 56 U/L	Significantly elevated (often >5 to 10 times the upper limit of normal)
Aspartate Aminotransferase (AST)	10 to 40 U/L	Significantly elevated, indicating acute or chronic hepatocellular injury
Serum Immunoglobulin G (IgG)	700 to 1600 mg/dL	Elevated (hypergammaglobulinemia), common in autoimmune hepatitis
Total Bilirubin	0.2 to 1.2 mg/dL	Elevated (jaundice), indicating impaired hepatic excretion or severe necrosis
Anti-Liver Cytosol Type 1 (Anti-LC1)	Negative	Positive, often co-existing with Anti-LKM-1 in AIH-2
Serum Albumin	3.5 to 5.0 g/dL	Decreased, indicating impaired hepatic synthetic function in advanced disease
Prothrombin Time (PT / INR)	INR: 0.8 to 1.2	Prolonged (INR > 1.5), indicating severe acute liver injury or advanced cirrhosis

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Test Zone Diagnostic Center for Anti LKM (Anti Liver Kidney Microsomal Abs)?

• Experienced healthcare professionals and clinical pathologists specializing in immunology and hepatology.
• Patient-focused care ensuring a comfortable, stress-free blood collection experience.
• Quality diagnostic services utilizing advanced automated ELISA and immunofluorescence technologies.
• Professional reporting with multi-level verification for maximum clinical accuracy.
• Modern diagnostic approach incorporating international quality control standards.
• Comfortable environment at our state-of-the-art collection centers in Lahore.
• Convenient location with easy accessibility and ample parking facilities.
• Commitment to accurate diagnosis with rapid turnaround times and secure online report access.